Continuous infusion during total joint arthroplasty in Japanese haemophilia A patients: comparison study among two recombinants and one plasma-derived factor VIII-Reference-Cited by-同舟云学术

Continuous infusion during total joint arthroplasty in Japanese haemophilia A patients: comparison study among two recombinants and one plasma-derived factor VIII

Published:2010-08-24 Issue:5 Volume:16 Page:740-746
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

TAKEDANI H.

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2010.02244.x/fullpdf

Reference19 articles.

1. Intermittent injections vs. continuous infusion of factor VIII in haemophilia patients undergoing major surgery;Batorova;Br J Haematol,2000

2. Continuous infusion of factor concentrates in children with haemophilia A in comparison with bolus injections;Bidlingmaier;Haemophilia,2006

3. The pharmacokinetics of coagulation factors;Lee;Haemophilia,2006

4. Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia;Martinowitz;Haemophilia,2009

5. Surgical evaluation of a recombinant factor VIII prepared using a plasma/albumin-free method: efficacy and safety of Advate in previously treated patients;Negrier;Thromb Haemost,2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rates of venous thromboembolism and use of thromboprophylaxis after major orthopedic surgery in patients with congenital hemophilia A or B: a systematic review;Journal of Thrombosis and Haemostasis;2024-04

2. Continuous Infusion of Factor VIII and von Willebrand Factor in Surgery: Trials with pdFVIII LFB or pdVWF LFB in Patients with Bleeding Disorders;Thrombosis and Haemostasis;2022-05-31

3. Stability of Turoctocog Alfa, a Recombinant Factor VIII Product, during Continuous Infusion In Vitro;TH Open;2020-10

4. Strategies for Individualized Dosing of Clotting Factor Concentrates and Desmopressin in Hemophilia A and B;Therapeutic Drug Monitoring;2019-04

5. Continuous infusion of coagulation factor concentrates during intensive treatment;Haemophilia;2017-09-05